Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to determine efficacy and safety of 0.75% topical capsaicin
nanoparticle preparation versus placebo in patient with painful diabetic neuropathy.